Characterization of a monoclonal antibody specific to California serogroup orthobunyaviruses and development as a chimeric immunoglobulin M-positive control in human diagnostics

ABSTRACT California serogroup viruses (CSGVs) of medical importance in the United States include La Crosse virus, Jamestown Canyon virus (JCV), California encephalitis virus, and snowshoe hare virus. Current diagnosis of CSGVs relies heavily on serologic techniques for detecting immunoglobulin M (Ig...

Full description

Bibliographic Details
Main Authors: Jordan A. Powers, Karen L. Boroughs, Sierra Mikula, Christin H. Goodman, Emily H. Davis, Elisa M. Thrasher, Holly R. Hughes, Brad J. Biggerstaff, Amanda E. Calvert
Format: Article
Language:English
Published: American Society for Microbiology 2023-10-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.01966-23
_version_ 1797658134704029696
author Jordan A. Powers
Karen L. Boroughs
Sierra Mikula
Christin H. Goodman
Emily H. Davis
Elisa M. Thrasher
Holly R. Hughes
Brad J. Biggerstaff
Amanda E. Calvert
author_facet Jordan A. Powers
Karen L. Boroughs
Sierra Mikula
Christin H. Goodman
Emily H. Davis
Elisa M. Thrasher
Holly R. Hughes
Brad J. Biggerstaff
Amanda E. Calvert
author_sort Jordan A. Powers
collection DOAJ
description ABSTRACT California serogroup viruses (CSGVs) of medical importance in the United States include La Crosse virus, Jamestown Canyon virus (JCV), California encephalitis virus, and snowshoe hare virus. Current diagnosis of CSGVs relies heavily on serologic techniques for detecting immunoglobulin M (IgM), an indication of a recent CSGV infection. However, human-positive control sera reactive to viruses in the serogroup are scarce because detection of recent infections is rare. Here, we describe the development of new murine monoclonal antibodies (MAbs) reactive to CSGVs and the engineering of a human-murine chimeric antibody by combining the variable regions of the broadly CSGV cross-reactive murine MAb, 3-3B6/2-3B2 and the constant region of the human IgM. MAb 3-3B6/2-3B2 recognizes a tertiary epitope on the Gn/Gc heterodimer, and epitopes important in JCV neutralization were mapped to the Gc glycoprotein. This engineered human IgM constitutively expressed in a HEK-293 stable cell line can replace human-positive control sera in diagnostic serological techniques such as IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA). Compared to the parent murine MAbs, the human-chimeric IgM antibody had identical serological activity to CSGVs in ELISA and demonstrated equivalent reactivity compared to human immune sera in the MAC-ELISA. Importance Orthobunyaviruses in the California serogroup cause severe neurological disease in children and adults. While these viruses are known to circulate widely in North America, their occurrence is rare. Serological testing for CSGVs is hindered by the limited availability and volumes of human-positive specimens needed as controls in serologic assays. Here, we described the development of a murine monoclonal antibody cross-reactive to CSGVs engineered to contain the variable regions of the murine antibody on the backbone of human IgM. The chimeric IgM produced from the stably expressing HEK293 cell line was evaluated for use as a surrogate human-positive control in a serologic diagnostic test.
first_indexed 2024-03-11T17:55:45Z
format Article
id doaj.art-0e7ed0eb135b43f9ad1ca44823389453
institution Directory Open Access Journal
issn 2165-0497
language English
last_indexed 2024-03-11T17:55:45Z
publishDate 2023-10-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj.art-0e7ed0eb135b43f9ad1ca448233894532023-10-17T13:04:36ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972023-10-0111510.1128/spectrum.01966-23Characterization of a monoclonal antibody specific to California serogroup orthobunyaviruses and development as a chimeric immunoglobulin M-positive control in human diagnosticsJordan A. Powers0Karen L. Boroughs1Sierra Mikula2Christin H. Goodman3Emily H. Davis4Elisa M. Thrasher5Holly R. Hughes6Brad J. Biggerstaff7Amanda E. Calvert8Division of Vector-Borne Diseases, U.S. Centers for Disease Control and Prevention , Fort Collins, Colorado, USADivision of Vector-Borne Diseases, U.S. Centers for Disease Control and Prevention , Fort Collins, Colorado, USADivision of Vector-Borne Diseases, U.S. Centers for Disease Control and Prevention , Fort Collins, Colorado, USADivision of Vector-Borne Diseases, U.S. Centers for Disease Control and Prevention , Fort Collins, Colorado, USADivision of Vector-Borne Diseases, U.S. Centers for Disease Control and Prevention , Fort Collins, Colorado, USADivision of Vector-Borne Diseases, U.S. Centers for Disease Control and Prevention , Fort Collins, Colorado, USADivision of Vector-Borne Diseases, U.S. Centers for Disease Control and Prevention , Fort Collins, Colorado, USADivision of Vector-Borne Diseases, U.S. Centers for Disease Control and Prevention , Fort Collins, Colorado, USADivision of Vector-Borne Diseases, U.S. Centers for Disease Control and Prevention , Fort Collins, Colorado, USAABSTRACT California serogroup viruses (CSGVs) of medical importance in the United States include La Crosse virus, Jamestown Canyon virus (JCV), California encephalitis virus, and snowshoe hare virus. Current diagnosis of CSGVs relies heavily on serologic techniques for detecting immunoglobulin M (IgM), an indication of a recent CSGV infection. However, human-positive control sera reactive to viruses in the serogroup are scarce because detection of recent infections is rare. Here, we describe the development of new murine monoclonal antibodies (MAbs) reactive to CSGVs and the engineering of a human-murine chimeric antibody by combining the variable regions of the broadly CSGV cross-reactive murine MAb, 3-3B6/2-3B2 and the constant region of the human IgM. MAb 3-3B6/2-3B2 recognizes a tertiary epitope on the Gn/Gc heterodimer, and epitopes important in JCV neutralization were mapped to the Gc glycoprotein. This engineered human IgM constitutively expressed in a HEK-293 stable cell line can replace human-positive control sera in diagnostic serological techniques such as IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA). Compared to the parent murine MAbs, the human-chimeric IgM antibody had identical serological activity to CSGVs in ELISA and demonstrated equivalent reactivity compared to human immune sera in the MAC-ELISA. Importance Orthobunyaviruses in the California serogroup cause severe neurological disease in children and adults. While these viruses are known to circulate widely in North America, their occurrence is rare. Serological testing for CSGVs is hindered by the limited availability and volumes of human-positive specimens needed as controls in serologic assays. Here, we described the development of a murine monoclonal antibody cross-reactive to CSGVs engineered to contain the variable regions of the murine antibody on the backbone of human IgM. The chimeric IgM produced from the stably expressing HEK293 cell line was evaluated for use as a surrogate human-positive control in a serologic diagnostic test.https://journals.asm.org/doi/10.1128/spectrum.01966-23La Crosse virusJamestown Canyon virusimmunoglobulin MserologyimmunodiagnosticsCalifornia serogroup viruses
spellingShingle Jordan A. Powers
Karen L. Boroughs
Sierra Mikula
Christin H. Goodman
Emily H. Davis
Elisa M. Thrasher
Holly R. Hughes
Brad J. Biggerstaff
Amanda E. Calvert
Characterization of a monoclonal antibody specific to California serogroup orthobunyaviruses and development as a chimeric immunoglobulin M-positive control in human diagnostics
Microbiology Spectrum
La Crosse virus
Jamestown Canyon virus
immunoglobulin M
serology
immunodiagnostics
California serogroup viruses
title Characterization of a monoclonal antibody specific to California serogroup orthobunyaviruses and development as a chimeric immunoglobulin M-positive control in human diagnostics
title_full Characterization of a monoclonal antibody specific to California serogroup orthobunyaviruses and development as a chimeric immunoglobulin M-positive control in human diagnostics
title_fullStr Characterization of a monoclonal antibody specific to California serogroup orthobunyaviruses and development as a chimeric immunoglobulin M-positive control in human diagnostics
title_full_unstemmed Characterization of a monoclonal antibody specific to California serogroup orthobunyaviruses and development as a chimeric immunoglobulin M-positive control in human diagnostics
title_short Characterization of a monoclonal antibody specific to California serogroup orthobunyaviruses and development as a chimeric immunoglobulin M-positive control in human diagnostics
title_sort characterization of a monoclonal antibody specific to california serogroup orthobunyaviruses and development as a chimeric immunoglobulin m positive control in human diagnostics
topic La Crosse virus
Jamestown Canyon virus
immunoglobulin M
serology
immunodiagnostics
California serogroup viruses
url https://journals.asm.org/doi/10.1128/spectrum.01966-23
work_keys_str_mv AT jordanapowers characterizationofamonoclonalantibodyspecifictocaliforniaserogrouporthobunyavirusesanddevelopmentasachimericimmunoglobulinmpositivecontrolinhumandiagnostics
AT karenlboroughs characterizationofamonoclonalantibodyspecifictocaliforniaserogrouporthobunyavirusesanddevelopmentasachimericimmunoglobulinmpositivecontrolinhumandiagnostics
AT sierramikula characterizationofamonoclonalantibodyspecifictocaliforniaserogrouporthobunyavirusesanddevelopmentasachimericimmunoglobulinmpositivecontrolinhumandiagnostics
AT christinhgoodman characterizationofamonoclonalantibodyspecifictocaliforniaserogrouporthobunyavirusesanddevelopmentasachimericimmunoglobulinmpositivecontrolinhumandiagnostics
AT emilyhdavis characterizationofamonoclonalantibodyspecifictocaliforniaserogrouporthobunyavirusesanddevelopmentasachimericimmunoglobulinmpositivecontrolinhumandiagnostics
AT elisamthrasher characterizationofamonoclonalantibodyspecifictocaliforniaserogrouporthobunyavirusesanddevelopmentasachimericimmunoglobulinmpositivecontrolinhumandiagnostics
AT hollyrhughes characterizationofamonoclonalantibodyspecifictocaliforniaserogrouporthobunyavirusesanddevelopmentasachimericimmunoglobulinmpositivecontrolinhumandiagnostics
AT bradjbiggerstaff characterizationofamonoclonalantibodyspecifictocaliforniaserogrouporthobunyavirusesanddevelopmentasachimericimmunoglobulinmpositivecontrolinhumandiagnostics
AT amandaecalvert characterizationofamonoclonalantibodyspecifictocaliforniaserogrouporthobunyavirusesanddevelopmentasachimericimmunoglobulinmpositivecontrolinhumandiagnostics